IQV
IQVIA Holdings Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.05% · Russell 1000 0.05% · Russell 3000 0.04% · US Stock Market 0.04% · MSCI World 0.03% · MSCI ACWI 0.03%$261.77+1.74%
as of market close, Sep 11, 2026
☾ AH — —
IQV — IQVIA Holdings Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
80.0100.0120.0140.0160.0180.0200.0220.0240.0260.0020.0M40.0M$261.77—20162019202120242026
2026-09-11
Price$261.77
MA20$201.35
MA50$199.48
Vol8.4M
Key stats
Price data
- Price
- $261.77
- Change YTD
- +16.13%
- Next earnings
- Oct 27, 2026
- Market cap
- 43.7B
- Enterprise value
- 58.1B
- Shares outstanding
- 166.9M
- 52W low
- $154.50
- 52W high
- $271.80
- From 52W high
- -3.69%
- From 52W low
- +69.43%
- 52W range
- 91%
- Beta
- 1.17
Volume
- Rel volume
- 1.11×
- 30D volume
- 1.3M
- 30D $ vol
- 322M
Fundamentals
- Sales (ttm)
- 16.6B
- Sales/share
- $99.65
- EPS (ttm)
- $8.07
- FCF (ttm)
- 2.1B
- FCF/share
- $12.68
- Book value/share
- $37.27
- Net margin
- 8.33%
- ROE
- 22.26%
- ROA
- 4.67%
- Debt / equity
- 2.25×
- Current ratio
- 0.75
Growth (CAGR, ttm) · 10Y
- Sales
- +7.33%+4.69%+6.72%+10.96%
- Net income
- +3.83%+9.49%+27.63%+13.03%
- FCF
- -2.17%+11.95%+0.74%+14.12%
- Shares
- -3.53%-3.47%-2.73%+3.38%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +9.91%+13.16%+30.91%+9.39%
- Sales/share
- +11.25%+8.45%+9.72%+7.33%
- FCF/share
- +1.40%+15.97%+3.57%+10.39%
- Book value/share
- +7.89%+5.25%+3.72%n/a
- Price
- +37.30%+6.72%+0.10%+13.00%
- Total return
- +37.30%+6.72%+0.10%+13.00%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 32.4×
- P/OI (ttm)
- 19.9×
- Fwd P/E
- 18.5×
- P/S (ttm)
- 2.6×
- P/B (mrq)
- 7.0×
- P/FCF (ttm)
- 20.6×
- EV/EBITDA (fy)
- 17.3×
- EV/Sales (ttm)
- 3.5×
- FCF yield (ttm)
- 4.84%
- Buyback yield (realized, 1y)
- 3.53%
- Shareholder yield (realized, 1y)
- 3.53%
- Buyback yield (cash, ttm)
- 3.25%
- Shareholder yield (cash, ttm)
- 3.25%
Vs own 10Y history
- P/E
- 37th
- P/OI
- 24th
- P/S
- 46th
- P/B
- 82nd
- P/FCF
- 24th
Bar = where today’s multiple sits in IQV’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · windows as of 2026-09-11
1D
+1.74%
5D
-3.63%
1M
+8.30%
3M
+44.58%
YTD
+16.13%
1Y
+42.37%
5Y
-1.30%
Financial statements
Open full IQV financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -8.44% | -0.65% |
| JNJ | Johnson & Johnson | +2.31% | -0.29% |
| ABBV | AbbVie Inc. | +3.36% | +0.83% |
| MRK | Merck & Co. Inc. | +8.28% | -0.54% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -6.53% | -2.37% |
| TMO | Thermo Fisher Scientific Inc. | +1.13% | +1.10% |
| AMGN | Amgen Inc. | -8.80% | -1.34% |
| GILD | Gilead Sciences Inc. | +5.78% | -0.75% |
IQVIA Holdings Inc. (IQV) trades at $261.77 with a live price and an interactive chart covering 13+ years of daily price history, plus key valuation metrics. ChartRow also publishes IQV’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full IQV financial statements →
